Injury guide

UPDATED FEB 2026

PFAS Thyroid Disease and Thyroid Cancer Lawsuit

Part of the PFAS Water Contamination investigation

The short answer

PFAS disrupt thyroid hormone signaling by mimicking and competing with thyroid hormones at receptor and transport protein binding sites. Women are disproportionately affected.

Diagnosed thyroid disease requiring medication (hypothyroidism, hyperthyroidism, Hashimoto's thyroiditis) and thyroid cancer are recognized injury categories in MDL 2873. A 2018 Mount Sinai study found significantly elevated thyroid cancer risk with higher serum PFAS concentrations.

People's Justice Research TeamUpdated February 21, 2026Fact-checked

Verified against court and regulatory records · No upfront fees · Your information is never sold

Free Case Review

Check your eligibility — free

Answer 2-3 quick questions to review your potential case.

Free · Confidential · About 2 minutes · A case specialist responds within 1 business day

Your answers are never sold or shared without your consent.

How PFAS Disrupt the Thyroid — The Mechanism

PFAS molecules share structural similarities with thyroid hormones (T3 and T4) and with the thyroid hormone transport proteins (transthyretin and thyroid-binding globulin) that carry hormones in the bloodstream. PFAS compete with thyroid hormones for binding sites on these transport proteins, reducing the availability of thyroid hormones in circulation. PFAS also interfere with the enzymes responsible for thyroid hormone synthesis in the thyroid gland and disrupt thyroid-stimulating hormone (TSH) signaling from the pituitary. The result is a range of thyroid dysfunction: hypothyroidism (insufficient thyroid hormone), hyperthyroidism (excess thyroid hormone signaling), thyroid nodule formation, and, in some cases, thyroid cancer through PFAS-driven disruption of thyroid cell proliferation controls. The C8 Health Project and multiple European cohort studies have documented elevated rates of thyroid disease in PFAS-exposed communities.

Thyroid Disease vs. Thyroid Cancer — Both Are Compensable

An important feature of PFAS thyroid claims is that both thyroid disease (non-cancer thyroid dysfunction requiring medication management) and thyroid cancer are recognized injury categories in MDL 2873. Many mass tort cases compensate only cancer diagnoses. PFAS thyroid claims extend the eligible claimant population to include the much larger group of individuals with PFAS-exposed hypothyroidism and hyperthyroidism requiring lifelong levothyroxine or methimazole management. While thyroid disease claims are valued lower than cancer claims — estimated in the $150,000–$300,000 range — the sheer number of potential thyroid disease claimants makes this a significant volume category. Thyroid cancer claims, particularly papillary thyroid carcinoma (the most common form), are valued in the $250,000–$500,000 range depending on extent of surgery, radioactive iodine treatment, and ongoing monitoring requirements.

Women and PFAS Thyroid Claims

Women are approximately three times more likely than men to develop thyroid disease, and PFAS exposure compounds this baseline risk. Military spouses who lived in on-base housing, women in contaminated communities who drank municipal tap water, and women in farming communities with biosolids PFAS exposure represent significant populations with potential thyroid disease and thyroid cancer claims. For military families specifically, spouses often spent years in on-base housing across multiple contaminated installations, accumulating PFAS exposure at multiple high-contamination sites. Female veterans who themselves served at contaminated installations also have thyroid claims. An attorney can evaluate both the exposure history (multiple installation duty stations are additive) and the thyroid diagnosis documentation to assess claim strength.

Dive deeper

Related Guides

11 GUIDES

The full investigation

Part of the PFAS Water Contamination Investigation